Research Use Only

21+ Age Verification

How2Pep is an independent, research-grade peptide reference. Nothing here is medical advice or approved for human consumption. To enter, confirm you are 21 years of age or older and provide your email.

Your email is stored to verify access and comply with research-use documentation. We do not sell or share your information.

SingleGrowth Hormone

Sermorelin 10mg

A truncated synthetic GHRH analog studied for its ability to stimulate endogenous pituitary growth hormone secretion in nightly research protocols.

Mechanism

Binds selectively to pituitary GHRH receptors to trigger episodic, endogenous growth hormone secretion while preserving physiological somatostatin feedback control.

Dosing

Documented laboratory protocols initiate evaluation with an introductory nightly dose of 100 mcg administered subcutaneously prior to rest.

Reconstitution

Reconstituting a 10 mg vial with 3.0 mL of bacteriostatic water yields an approximate working concentration of 3.33 mg/mL (3,333 mcg/mL).

Storage

Store the unmixed lyophilized vial refrigerated between 2 and 8 °C protected from light, and keep the reconstituted solution refrigerated at 2 to 8 °C without freezing, utilizing it within 10 to 14 days.

Mix & measure Sermorelin 10mg

Pre-filled with this protocol's recommended BAC water and documented starting dose — edit any field to run your own numbers.

Mix & measure Sermorelin 10mg

Vial strength → BAC water → target dose

mL
Concentration3.33mg/mL
Draw volume0.030mL
On the syringe3.00units

Total doses in vial: 100.0

100u80u60u40u20u0

U-100 syringe: 100 units = 1 mL

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Advanced calculator →

Dosing Chart

Phase / Day(s)Dose & FrequencyVolume (U-100 units / mL)
Weeks 1–2200 mcg (1× nightly)~6 units (0.06 mL)
Weeks 3–4300 mcg (1× nightly)~9 units (0.09 mL)
Weeks 5–6400 mcg (1× nightly)~12 units (0.12 mL)
Weeks 7–8500 mcg (1× nightly)~15 units (0.15 mL)

Reconstitution Steps

  1. 1

    Aspirate exactly 3.0 mL of sterile bacteriostatic water using a fresh syringe.

  2. 2

    Introduce the diluent gently along the interior glass wall of the 10 mg vial to avoid peptide shearing and excess foam.

  3. 3

    Swirl the vial with slow, circular motions until the lyophilized cake is fully dissolved without vigorous agitation.

  4. 4

    Affix a label noting the reconstitution date and resulting 3.33 mg/mL concentration, then place immediately into refrigerated storage at 2–8 °C away from light.

Supplies Needed

Peptide Vial

Peptide Vial

Lyophilized Sermorelin acetate target compound (10 mg)

Insulin Syringes (U-100)

Insulin Syringes (U-100)

Calibrated 1 mL syringes for precise measurement of microgram aliquots

Bacteriostatic Water

Bacteriostatic Water

Sterile diluent with 0.9% benzyl alcohol preservative (3.0 mL required per vial)

Alcohol Swabs

Alcohol Swabs

70% isopropyl alcohol prep pads for disinfecting vial stoppers and injection surfaces

Why researchers study it

1

Endogenous pulsatile GH and downstream IGF-1 induction

2

Somatotropic regulation during deep slow-wave sleep cycles

3

Adipose lipolysis and lean tissue metabolic pathways

4

Endocrine signaling changes during age-related hormonal senescence

These describe what is being studied, not proven benefits, approved uses, or promised results.

Overview

Sermorelin is a synthetic peptide representing the first 29 amino acids of human growth hormone-releasing hormone, corresponding to the functional region responsible for pituitary stimulation. By interacting directly with somatotropes in the anterior pituitary gland, it prompts the natural release of endogenous somatotropin while maintaining normal endocrine feedback mechanisms. In laboratory and experimental models, sermorelin serves as a non-exogenous route to assess somatotropic function without completely suppressing native feedback loops. Unlike recombinant somatropin, its action depends heavily upon an intact, functioning pituitary axis and respects normal physiological inhibitory signals, notably somatostatin regulation.

References

  1. 1.Prakash & Goa, Drugs, 1999 — Review of sermorelin in the diagnosis and management of idiopathic growth hormone deficiency
  2. 2.RxList, Sermorelin Acetate Monograph, 2008 — Clinical monograph covering sermorelin preparation, dosing considerations, and discontinuation context
  3. 3.Van Cauter et al., Sleep, 1998 — Endogenous growth hormone secretion patterns and relationship to slow-wave sleep physiology
  4. 4.Mayo Clinic, Clinical Pharmacology, 2020 — Overview of sermorelin injection route, handling, and preservation parameters

Supplies Needed

Suggested supplier

Research use only. Listing a supplier is not an endorsement of any protocol on this site, and nothing sold there is approved for human use.

Related protocols

View all
How2Pep

An independent, research-grade peptide reference library. Reconstitution, dosing, and storage protocols — evidence-referenced and not affiliated with any vendor.

Notice

Research use only. Nothing on this site is medical advice or approved for human consumption. Protocols reference peer-reviewed data where available.

© 2026 How2Pep · Independent reference

Admin

Educational research information only.